Stock Titan Trading tools for traders and investors.

-

02:24:51 AM

Last PRPH Stock Market News

PRPH - ProPhase Labs Inc

02/09/21 8:30 AM

Nasdaq : PRPH

ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology

RHEA-AI

neutral

02/01/21 8:30 AM

Nasdaq : PRPH

ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has surpassed its

RHEA-AI

positive

01/29/21 8:30 AM

Nasdaq : PRPH

ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the opening of its 25,000 square foot facility in Garden City,

RHEA-AI

positive

01/21/21 4:30 PM

Nasdaq : PRPH

ProPhase Labs, Inc. Announces Closing of Public Offering

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock at a public offering price of $12.50 per

RHEA-AI

neutral

01/18/21 9:50 PM

Nasdaq : PRPH

ProPhase Labs Announces Pricing of Public Offering of Common Stock

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public offering of 3,000,000 shares of common stock at an offering price of $12.50 per share, for gross

RHEA-AI

neutral

01/15/21 5:21 PM

Nasdaq : PRPH

ProPhase Labs Announces Proposed Public Offering of Common Stock

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed underwritten public offering of its common stock. ThinkEquity, a division of Fordham Financial Management,

RHEA-AI

neutral

01/11/21 8:30 AM

Nasdaq : PRPH

ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time

ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase Labs"), a diversified medical science and technology company, today

RHEA-AI

neutral

01/05/21 12:10 PM

Nasdaq : PRPH

ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive securities purchase agreement with certain institutional and accredited investors to purchase, in a

RHEA-AI

neutral

12/08/20 4:15 PM

Nasdaq : PRPH

ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology

RHEA-AI

neutral

11/16/20 8:30 AM

Nasdaq : PRPH

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020

ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for the three months ended September 30, 2020, compared to net sales of $2.8 million for the three months

RHEA-AI

neutral